Cargando…

Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling

PURPOSE: This study investigates the diagnostic and prognostic biomarker potential of miRNAs in prostate cancer (PC). RESULTS: We identified several new deregulated miRNAs between non-malignant (NM) and PC tissue samples and between more/less aggressive PC subgroups. We also developed and validated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kristensen, Helle, Thomsen, Anni R., Haldrup, Christa, Dyrskjøt, Lars, Høyer, Søren, Borre, Michael, Mouritzen, Peter, Ørntoft, Torben F., Sørensen, Karina Dalsgaard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058715/ https://www.ncbi.nlm.nih.gov/pubmed/27120795 http://dx.doi.org/10.18632/oncotarget.8953

Ejemplares similares

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2014)

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2015)

Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases
por: Schmidt, Linnéa, et al.
Publicado: (2018)

Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis
por: Nørgaard, Maibritt, et al.
Publicado: (2017)

Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients
por: Møller, Mia, et al.
Publicado: (2017)

Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
por: Haldrup, Christa, et al.
Publicado: (2018)

High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer
por: Strand, Siri H., et al.
Publicado: (2015)

Epigenetic silencing of MEIS2 in prostate cancer recurrence
por: Nørgaard, Maibritt, et al.
Publicado: (2019)

Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients
por: Schmidt, L, et al.
Publicado: (2018)

Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer
por: Sørensen, K D, et al.
Publicado: (2013)

Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
por: Bjerre, Marianne T., et al.
Publicado: (2019)

RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy
por: Strand, Siri H., et al.
Publicado: (2016)

Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer
por: Storebjerg, Tine Maj, et al.
Publicado: (2018)

Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study
por: Kirkegaard, Pia, et al.
Publicado: (2018)

Investigation of enzalutamide, docetaxel, and cabazitaxel resistance in the castration resistant prostate cancer cell line C4 using genome-wide CRISPR/Cas9 screening
por: Haldrup, Jakob, et al.
Publicado: (2023)

Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome
por: Strand, Siri H., et al.
Publicado: (2020)

Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential
por: Fredsøe, Jacob, et al.
Publicado: (2020)

5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors
por: Kristensen, Gitte, et al.
Publicado: (2019)

Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
por: Reinert, Thomas, et al.
Publicado: (2012)

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer
por: Laurberg, Jens Reumert, et al.
Publicado: (2014)

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
por: Thomsen, Mathilde Borg Houlberg, et al.
Publicado: (2017)

Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder
por: Herbsleb, Malene, et al.
Publicado: (2008)

Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts
por: Brems-Eskildsen, Anne Sofie, et al.
Publicado: (2010)

An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes
por: Bekker-Jensen, Dorte B., et al.
Publicado: (2017)

Prognostic DNA Methylation Markers for Prostate Cancer
por: Strand, Siri H., et al.
Publicado: (2014)

Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array
por: Tørring, N, et al.
Publicado: (2007)

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
por: Egerod, Frederikke Lihme, et al.
Publicado: (2009)

Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP
por: Fredsøe, Jacob, et al.
Publicado: (2023)

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer
por: Nordentoft, Iver, et al.
Publicado: (2012)

Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling
por: Salachan, Paul Vinu, et al.
Publicado: (2022)

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma
por: Dyrskjøt, L, et al.
Publicado: (2012)

Identifying aggressive prostate cancer foci using a DNA methylation classifier
por: Mundbjerg, Kamilla, et al.
Publicado: (2017)

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
por: Zieger, Karsten, et al.
Publicado: (2009)

Are microRNAs located in genomic regions associated with cancer?
por: Lamy, P, et al.
Publicado: (2006)

The transcriptional landscape and biomarker potential of circular RNAs in prostate cancer
por: Hansen, Emma Bollmann, et al.
Publicado: (2022)

Next-Generation Sequencing of RNA and DNA Isolated from Paired Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Samples of Human Cancer and Normal Tissue
por: Hedegaard, Jakob, et al.
Publicado: (2014)

epiG: statistical inference and profiling of DNA methylation from whole-genome bisulfite sequencing data
por: Vincent, Martin, et al.
Publicado: (2017)

High-Throughput and Automated Acoustic Trapping of Extracellular Vesicles to Identify microRNAs With Diagnostic Potential for Prostate Cancer
por: Ku, Anson, et al.
Publicado: (2021)

Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis
por: Thorsen, Kasper, et al.
Publicado: (2011)

Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by (68)Ga-PSMA PET/CT
por: Christensen, Mads T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5noncumvhihousjn2ehih94qvv